There’s No Reply At All: It’s Never a Good Idea To Ignore FDA During an Inspection (and, in Fact, It’s Illegal)

Arnall Golden Gregory LLP
Contact

Rule Number One: If a facility is regulated by the Food and Drug Administration, the agency may inspect it (although there are some boundaries, not discussed here).1 Rule Number Two: Assuming Rule Number One applies, the facility cannot deny FDA access to those records and information to which it is entitled. In fact, it is a prohibited act.2 Recently, FDA issued a Warning Letter to a manufacturer of over-the-counter drug products (including hand sanitizers) reminding industry of Rules One and Two.3 Reading the Warning Letter reminded the author of the 1981 classic rock song by Genesis, “No Reply At All.”

In the Warning Letter, the agency wrote that it attempted to contact the company by email and by telephone several times, but to no avail. It sent a follow-up written request for written records by certified return-receipt mail. Again, no response. Because the company did not respond, FDA found that it refused the agency access to inspect, which is a prohibited act. FDA directed the company to confirm or update its registration and/or drug listing status and said that if the company was not manufacturing the products, it should delist them.

Bottom Line: remember Rules One and Two and, to take another song from the Genesis catalogue, make sure there is no misunderstanding and reply to FDA.

[1] 21 U.S.C. § 374.

[2] 21 U.S.C. § 331(e).

[3] https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/healthmeds-inc-618484-09292021

Written by:

Arnall Golden Gregory LLP
Contact
more
less

Arnall Golden Gregory LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.